Amyloid-related imaging abnormalities (ARIA) in Alzheimer’s disease patients treated with bapineuzumab: A retrospective analysis

BACKGROUND: Amyloid-related imaging abnormalities (ARIA) have been reported in Alzheimer’s disease (AD) patients treated with bapineuzumab, a humanized monoclonal antibody to amyloid-β. ARIA includes MRI signal abnormalities suggestive of vasogenic edema and sulcal effusions (ARIA-E) and hemosiderin...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Sperling, Reisa, Salloway, Stephen, Brooks, David J., Tampieri, Donatella, Barakos, Jerome, Fox, Nick C., Raskind, Murray, Sabbagh, Marwan, Honig, Lawrence S., Porsteinsson, Anton P., Lieberburg, Ivan, Arrighi, H. Michael, Morris, Kristen A., Lu, Yuan, Liu, Enchi, Gregg, Keith M., Brashear, Robert H., Kinney, Gene G., Black, Ronald, Grundman, Michael
Materialtyp: Artigo
Språk:Inglês
Publicerad: 2012
Ämnen:
Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4063417/
https://ncbi.nlm.nih.gov/pubmed/22305802
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/S1474-4422(12)70015-7
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk